Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.
Groheux D, Hindié E, Giacchetti S, Delord M, Hamy AS, de Roquancourt A, Vercellino L, Berenger N, Marty M, Espié M.
J Nucl Med. 2012 Feb;53(2):249-54. Epub 2012 Jan 12.
Related citations
PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma.
van Kruchten M, Glaudemans AW, de Vries EF, Beets-Tan RG, Schröder CP, Dierckx RA, de Vries EG, Hospers GA.
J Nucl Med. 2012 Feb;53(2):182-90. Epub 2012 Jan 12.
PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, Chodosh LA, Belka G, Thompson CB, Kung HF.
J Nucl Med. 2011 Dec;52(12):1947-55. Epub 2011 Nov 15.
PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
Oude Munnink TH, Arjaans ME, Timmer-Bosscha H, Schröder CP, Hesselink JW, Vedelaar SR, Walenkamp AM, Reiss M, Gregory RC, Lub-de Hooge MN, de Vries EG.
J Nucl Med. 2011 Dec;52(12):2001-8. Epub 2011 Nov 9.
(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL.
J Nucl Med. 2011 Nov;52(11):1819-26. Epub 2011 Oct 7.
The usefulness of a preoperative compact imager, a hand-held gamma-camera for breast cancer sentinel node biopsy: final results of a prospective double-blind, clinical study.
Kerrou K, Pitre S, Coutant C, Rouzier R, Ancel PY, Lebeaux C, Huchet V, Montravers F, Pascal O, Duval MA, Lefebvre F, Menard L, Uzan S, Charon Y, Barranger E.
J Nucl Med. 2011 Sep;52(9):1346-53. Epub 2011 Aug 17.
The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
Groheux D, Giacchetti S, Espié M, Vercellino L, Hamy AS, Delord M, Berenger N, Toubert ME, Misset JL, Hindié E.
J Nucl Med. 2011 Oct;52(10):1526-34. Epub 2011 Aug 30.
99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH, Choe YS, Paik JY, Lee KH.
J Nucl Med. 2011 Sep;52(9):1457-64. Epub 2011 Aug 17.
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT.
Kurdziel KA, Kalen JD, Hirsch JI, Wilson JD, Bear HD, Logan J, McCumisky J, Moorman-Sykes K, Adler S, Choyke PL.
J Nucl Med. 2011 Sep;52(9):1339-45. Epub 2011 Aug 17.
Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin.
Song S, Xiong C, Zhou M, Lu W, Huang Q, Ku G, Zhao J, Flores LG Jr, Ni Y, Li C.
J Nucl Med. 2011 May;52(5):792-9. Epub 2011 Apr 15.
Error occurred: cannot get document summary
CMIIT sponsors breast cancer imaging meeting at NIH.
Jochelson MS.
J Nucl Med. 2011 Apr;52(4):16N. No abstract available.
Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.
Tournier N, Valette H, Peyronneau MA, Saba W, Goutal S, Kuhnast B, Dollé F, Scherrmann JM, Cisternino S, Bottlaender M.
J Nucl Med. 2011 Mar;52(3):415-23. Epub 2011 Feb 14.
The sentinel node procedure in breast cancer: nuclear medicine as the starting point.
Hindié E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espié M.
J Nucl Med. 2011 Mar;52(3):405-14. Epub 2011 Feb 14. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on